These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24962223)

  • 1. Diagnostic and prognostic value of plasma adrenomedullin in COPD exacerbation.
    Meng DQ; Li XJ; Song XY; Xin JB; Yang WB
    Respir Care; 2014 Oct; 59(10):1542-9. PubMed ID: 24962223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD.
    Stolz D; Christ-Crain M; Morgenthaler NG; Miedinger D; Leuppi J; Müller C; Bingisser R; Struck J; Müller B; Tamm M
    Chest; 2008 Aug; 134(2):263-272. PubMed ID: 18490402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failure.
    Self WH; Storrow AB; Hartmann O; Barrett TW; Fermann GJ; Maisel AS; Struck J; Bergmann A; Collins SP
    Am J Emerg Med; 2016 Feb; 34(2):257-62. PubMed ID: 26577429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD.
    Stolz D; Breidthardt T; Christ-Crain M; Bingisser R; Miedinger D; Leuppi J; Mueller B; Tamm M; Mueller C
    Chest; 2008 May; 133(5):1088-94. PubMed ID: 18339792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of adrenomedullin and brain natriuretic peptide levels in acute rheumatic fever in adults.
    Bayram E; Kocatürk H; Yücel O; Atalay C; Colak MC; Ateşal S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):188-91. PubMed ID: 18524724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.
    Grolimund E; Kutz A; Marlowe RJ; Vögeli A; Alan M; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P;
    COPD; 2015 Jun; 12(3):295-305. PubMed ID: 25230352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.
    Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the expression and role of adrenomedullin and adrenomedullin receptor in patients with chronic obstructive pulmonary disease].
    Xu P; Dai AG; Zhou HD; Shen HW; Liu LH; Song WD
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Dec; 26(12):765-8. PubMed ID: 14720432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease.
    Mandal J; Roth M; Costa L; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respiration; 2015; 90(5):357-68. PubMed ID: 26447811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid receptor alpha: One of plasma biomarkers associated with exacerbation of chronic obstructive pulmonary disease.
    Heo JS; Park JS; Lee EJ; Kim TH; Jang AS; Park SW; Kim JN; Kim YG; Uh ST; Choi JS; Na JO; Kim YH; Jeong SH; Kim YB; Kim SR; Park CS
    COPD; 2014 Apr; 11(2):152-62. PubMed ID: 24111541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin.
    Stolz D; Boersma W; Blasi F; Louis R; Milenkovic B; Kostikas K; Aerts JG; Rohde G; Lacoma A; Rakic J; Boeck L; Castellotti P; Scherr A; Marin A; Hertel S; Giersdorf S; Torres A; Welte T; Tamm M
    Chest; 2014 Aug; 146(2):328-338. PubMed ID: 24722847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study.
    Mebazaa A; Geven C; Hollinger A; Wittebole X; Chousterman BG; Blet A; Gayat E; Hartmann O; Scigalla P; Struck J; Bergmann A; Antonelli M; Beishuizen A; Constantin JM; Damoisel C; Deye N; Di Somma S; Dugernier T; François B; Gaudry S; Huberlant V; Lascarrou JB; Marx G; Mercier E; Oueslati H; Pickkers P; Sonneville R; Legrand M; Laterre PF;
    Crit Care; 2018 Dec; 22(1):354. PubMed ID: 30583748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value for Mortality of Plasma Bioactive Adrenomedullin in Patients with Pulmonary Arterial Hypertension: A Sub Analysis of the Biomarker Study in the COHARD-PH Registry.
    Hartopo AB; Anggrahini DW; Dinarti LK; Schäfer AK; Bergmann A; Fachiroh J; Somma SD
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
    Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin refines mortality prediction by the BODE index in COPD: the "BODE-A" index.
    Stolz D; Kostikas K; Blasi F; Boersma W; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Hertel S; Giersdorf S; Tamm M
    Eur Respir J; 2014 Feb; 43(2):397-408. PubMed ID: 23794469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and role of adrenomedullin and its receptor in patients with chronic obstructive pulmonary disease.
    Xu P; Dai A; Zhou H; Shen H; Liu L; Song W
    Chin Med J (Engl); 2003 Jun; 116(6):863-7. PubMed ID: 12877796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of daily walking activity with biomarkers related to cardiac distress in patients with chronic obstructive pulmonary disease.
    Jehn M; Schindler C; Meyer A; Tamm M; Koehler F; Witt C; Schmidt-Trucksäss A; Stolz D
    Respiration; 2013; 85(3):195-202. PubMed ID: 23258247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics.
    Vizza CD; Letizia C; Badagliacca R; Sciomer S; Poscia R; Della Rocca G; Iacoboni C; Leonardo de L; Quattrucci S; Dario C; Luigi P; Fedele F
    Regul Pept; 2006 Sep; 136(1-3):85-91. PubMed ID: 16815566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness.
    Lundberg OHM; Lengquist M; Spångfors M; Annborn M; Bergmann D; Schulte J; Levin H; Melander O; Frigyesi A; Friberg H
    Crit Care; 2020 Nov; 24(1):636. PubMed ID: 33148300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality risk prediction in COPD by a prognostic biomarker panel.
    Stolz D; Meyer A; Rakic J; Boeck L; Scherr A; Tamm M
    Eur Respir J; 2014 Dec; 44(6):1557-70. PubMed ID: 25034566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.